IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,174,000 | -74.1% | 200,000 | -69.2% | 0.01% | -74.1% |
| Q2 2023 | $12,265,500 | -81.9% | 650,000 | -96.3% | 0.03% | -82.2% |
| Q1 2023 | $67,710,010 | +22.8% | 17,632,815 | +58.6% | 0.15% | +15.2% |
| Q4 2022 | $55,150,240 | +46.0% | 11,119,000 | +40.7% | 0.13% | +40.4% |
| Q3 2022 | $37,762,000 | -27.6% | 7,900,000 | -31.8% | 0.09% | -21.7% |
| Q2 2022 | $52,138,000 | -5.5% | 11,586,193 | 0.0% | 0.12% | +14.3% |
| Q1 2022 | $55,150,000 | -27.7% | 11,586,193 | +12.6% | 0.10% | -23.4% |
| Q4 2021 | $76,324,000 | +73.7% | 10,286,193 | +32.7% | 0.14% | +57.5% |
| Q3 2021 | $43,943,000 | -4.7% | 7,750,000 | +10.7% | 0.09% | -3.3% |
| Q2 2021 | $46,130,000 | +26.6% | 7,000,000 | +55.6% | 0.09% | +21.6% |
| Q1 2021 | $36,450,000 | +128.3% | 4,500,000 | +81.8% | 0.07% | +111.4% |
| Q4 2020 | $15,964,000 | – | 2,475,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |